SCHEMBL8792741

SCHEMBL8792741

CCOC(=O)CC1CC(=O)c2ccsc2S1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
HSD17B10 Q99714 2/20 0.38
CYP1A2 P05177 2/20 0.37
KMT2A Q03164 3/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 7/20 0.34
PKM P14618 2/20 0.34
MIF P14174 1/20 0.34
MEN1 O00255 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
PIN1 Q13526 1/20 0.33
PIN4 Q9Y237 1/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33
HTT P42858 1/20 0.33
HTR2C P28335 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8794212 0.81 HTT (0.32) TSHRHSD17B10ALDH1A1MAPK1KDM4E
SCHEMBL8793023 0.78 SIRT2 (0.39) HSD17B10CYP1A2KMT2AMAPTALDH1A1
SCHEMBL8793900 0.74 TSHR (0.35) TSHRHSD17B10CYP1A2KMT2AMAPT
SCHEMBL1123239 0.68 KDM4E (0.44) KMT2AALDH1A1MEN1KDM4EHTT
SCHEMBL3349385 0.68 KDM4E (0.44) KMT2AALDH1A1MEN1KDM4EHTT
SCHEMBL1122649 0.68 KDM4E (0.44) KMT2AALDH1A1MEN1KDM4EHTT
SCHEMBL6994471 0.68 ALDH1A1 (0.53) HSD17B10KMT2AMAPTALDH1A1MEN1
SCHEMBL8792427 0.66 LMNA (0.31)
SCHEMBL8793891 0.66 KMT2A (0.31) KMT2A
SCHEMBL8792164 0.65 TSHR (0.34) TSHRHSD17B10CYP1A2KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0452151-B1 Substituted aromatic sulfonamides as antiglaucoma agents MERCK & CO INC (US) 1997-07-16 EP disclosed
US-5334591-A Useful in the treatment of ocular hypertension and glaucoma MERCK & CO., INC. (US) 1994-08-02 US disclosed
US-5308863-A Carbonic anhydrase inhibitors MERCK & CO., INC. (US) 1994-05-03 US disclosed
EP-0543497-A1 Tricyclic thienothiopyrans as antiglancoma agents MERCK & CO. INC. (US) 1993-05-26 EP disclosed
US-5175284-A Glaucoma MERCK & CO., INC. (US) 1992-12-29 US disclosed
EP-0452151-A1 Substituted aromatic sulfonamides as antiglaucoma agents MERCK & CO. INC. (US) 1991-10-16 EP disclosed